{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:58:03Z","timestamp":1770065883375,"version":"3.49.0"},"reference-count":48,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T00:00:00Z","timestamp":1134345600000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:p> <jats:italic>\n            <jats:bold>Background:<\/jats:bold> In dilated cardiomyopathy (DCM) patients (pts) with cardiac resynchronization therapy (CRT) for ventricular dyssynchrony, long\u2010term predictors of mortality and morbidity remain poorly investigated.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Method and Results:<\/jats:bold> We reviewed data of 102 pts, 68 \u00b1 10 years, NYHA Class II\u2013IV (14 Class II, 67 Class III, 21 Class IV), who benefited from CRT (69 CRT, 33 CRT\u2010ICD). Fifty\u2010two patients had an ischemic DCM, 36 a previously implanted conventional PM\/ICD, 29 a permanent atrial fibrillation, and 19 needed dobutamine in the month preceding implant. QRS duration was 187 \u00b1 35 ms, left ventricular end\u2010diastolic diameter 72 \u00b1 10 mm, mitral regurgitation severity 1.9 \u00b1 0.8, echographic aorto\u2010pulmonary electromechanical delay 61.5 \u00b1 25 ms and septo\u2010lateral left intraventricular delay 86 \u00b1 56 ms, pulmonary artery pressure (PAP) 43 \u00b1 11 mmHg, angioscintigraphic left ventricular ejection fraction (EF) 20 \u00b1 9%, and right ventricular EF 30.5 \u00b1 14%. Over a mean follow\u2010up of 23 \u00b1 20 months, 26 pts died (18 heart failures (HFs), 1 arrhythmic storm, 7 noncardiac deaths). Positive univariate predictors of death from any cause were NYHA Class IV (P &lt; 0.001), and need for dobutamine the month preceding CRT (P &lt; 0.008), while use of \u03b2\u2010blocking agents (P &lt; 0.08) and left ventricular EF (P &lt; 0.09) were negative ones. NYHA Class IV was the only independent predictor at multivariate analysis (P &lt; 0.01). Survival at 24 months was 85% in Class II, 80% in Class III, and 37% in Class IV (II vs III, P = ns; III vs IV, P &lt; 0.001). When using a composite endpoint of death from any cause and unplanned rehospitalization for a major cardiovascular event, there were 48 events (14 HF deaths, 3 noncardiac deaths, 26 HF rehospitalizations, 2 paroxysmal atrial fibrillation, 2 sustained ventricular tachycardia, 1 nonfatal pulmonary embolism). Predictors of death from any cause\/unplanned rehospitalization for a major cardiovascular event in the follow\u2010up were NYHA Class IV (P &lt; 0.001), need for dobutamine during the month preceding CRT (P &lt; 0.002), and PAP (&lt;0.02). NYHA Class IV was the only independent predictor at multivariate analysis (P &lt; 0.05). Event\u2010free proportion at 24 months was 70% in Class II, 64% in Class III, and 37% in Class IV (II vs III, P = ns; III vs IV, P &lt; 0.01). When considering determinants of mortality only in NYHA Class IV patients, no variable was significantly correlated to mortality. Need for dobutamine during the last month preceding CRT did not add an adjunctive mortality risk.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Conclusion:<\/jats:bold> Baseline NYHA Class IV at implantation appears as the most important determinant of a poor clinical outcome in terms of both mortality and morbidity. No predictive criteria seem available for NYHA Class IV patients, in order to discriminate who will die after CRT and who will not. NYHA Class IV strongly influences the clinical outcome, suggesting that, in future studies planned on mortality and rehospitalization as major endpoints, baseline NYHA Class IV should be separately taken into account.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1540-8159.2005.00266.x","type":"journal-article","created":{"date-parts":[[2005,12,12]],"date-time":"2005-12-12T11:28:12Z","timestamp":1134386892000},"page":"1260-1270","source":"Crossref","is-referenced-by-count":23,"title":["Determinants of Mortality in Patients Undergoing Cardiac Resynchronization Therapy: Baseline Clinical, Echocardiographic, and Angioscintigraphic Evaluation Prior to Resynchronization"],"prefix":"10.1111","volume":"28","author":[{"given":"ANTONIO","family":"DE SISTI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JEAN\u2010FRAN\u00c7OIS","family":"TOUSSAINT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"THOMAS","family":"LAVERGNE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JACKY","family":"OLLITRAULT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ERIC","family":"ABERGEL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"OLIVIER","family":"PAZIAUD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MINA","family":"AIT SAID","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAIF","family":"SADER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JEAN\u2010YVES","family":"LE HEUZEY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"LOUIS","family":"GUIZE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,12]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103223441202"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)01895-8"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013168"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(02)02493-1"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2003.t01-1-00275.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)00716-5"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.08.028"},{"key":"e_1_2_8_9_2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jama.289.6.730","article-title":"Cardiac resynchronization and death from progressive heart failure. A meta\u2010analysis of randomized controlled trials","volume":"289","author":"Bradley DJ","year":"2003","journal-title":"JAMA"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032423"},{"key":"e_1_2_8_11_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland JG","year":"2005","journal-title":"N Engl J Med"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2006.00486.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000034512.90874.8E"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02010-7"},{"key":"e_1_2_8_15_2","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/hc0402.102623","article-title":"Tissue Doppler echocardiography evidences of reverses remodeling and improves synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure","volume":"105","author":"Yu CM","year":"2002","journal-title":"Circulation"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2003.06.016"},{"key":"e_1_2_8_17_2","first-page":"166","volume-title":"Cardiac Pacing in Clinical Practice","author":"Ritter F","year":"1998"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2000.110570"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00634-2"},{"key":"e_1_2_8_20_2","first-page":"534","volume-title":"Heart Disease: A Textbook of Cardiovascular Medicine","author":"Braunwald E","year":"2001"},{"key":"e_1_2_8_21_2","first-page":"756","article-title":"Predictors of prognosis in patients waiting heart transplantation","volume":"12","author":"Campana C","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00361-6"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(98)00007-2"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70251-6"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.83.5.505"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2002.3282"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"issue":"2","key":"e_1_2_8_28_2","first-page":"1A","article-title":"Consensus recommendations for the management of chronic heart failure","volume":"83","author":"Paker M","year":"1999","journal-title":"Am J Cardiol"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04560-8"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.92.9.2764"},{"key":"e_1_2_8_31_2","first-page":"VI17","article-title":"Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V\u2010HeFT VA Cooperative Studies Group","volume":"87","author":"Cintron G","year":"1993","journal-title":"Circulation"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.1.68"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00146-Q"},{"key":"e_1_2_8_34_2","first-page":"55","article-title":"Left ventricular ejection fraction in the thrombolytic era remains a powerful predictor of long\u2010term but not short\u2010term all\u2010cause, cardiac and arrhythmic mortality after myocardial infarction\u2014A secondary meta\u2010analysis of 2828 patients","volume":"85","author":"Yap Y","year":"2000","journal-title":"Heart"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001573-200405000-00009"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(83)80156-9"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00337-4"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01102-5"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(95)02502-2"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(99)00077-7"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.121264"},{"key":"e_1_2_8_42_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.122516"},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01347-3"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000035037.11968.5C"},{"key":"e_1_2_8_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.12.1401"},{"key":"e_1_2_8_46_2","first-page":"K152","article-title":"Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: Effect of upgrading to ventricular pacing after chronic right ventricular pacing","volume":"86","author":"Leon AR","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1540-8167.2004.04279.x"},{"issue":"1","key":"e_1_2_8_48_2","first-page":"58","article-title":"In patients with dilated cardiomyopathy and ventricular dyssynchrony, upgrading to cardiac resynchronization therapy is as beneficial as de novo implant","volume":"7","author":"De Sisti A","year":"2005","journal-title":"Europace"},{"key":"e_1_2_8_49_2","first-page":"1019","article-title":"Cardiac resynchronization therapy does not change mortality in Class IV CHF patients on continuous inotrope infusion with ICDs","volume":"26","author":"Makaty KJ","year":"2003","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2005.00266.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.2005.00266.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T15:57:32Z","timestamp":1697126252000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2005.00266.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["10.1111\/j.1540-8159.2005.00266.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2005.00266.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}